News from memed A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Dec 05, 2018, 09:00 ET DTRA Commits Additional Funds to MeMed's Innovative Bacterial Versus Viral Test and Point-of-Care Platform

MeMed today announced DTRA's expanded commitment to their point-of-care immunoassay platform and ground breaking bacterial versus viral host-response ...


Sep 20, 2018, 09:00 ET MeMed Raises Over $70 Million to Advance Pioneering Point-Of-Care Platform and Immune-Based Test for Distinguishing Bacterial Versus Viral Infections

MeMed today announced the completion of a new round of financing totaling over $70 million, with participation from new and existing investors...


May 15, 2018, 06:00 ET New Study Demonstrates Superiority of MeMed's ImmunoXpert™ Over Procalcitonin, CRP, HNL and Additional Biomarkers in Distinguishing Bacterial From Viral Infections

MeMed today announced publication of a large study that compared the diagnostic performance of MeMed's novel blood test, ImmunoXpert™, to...


Feb 06, 2018, 06:30 ET MeMed Secures Additional Funding From the Department of Defense

MeMed Ltd. announced today that it has been awarded a $4,079,159 grant by the DoD's Congressionally Directed Medical Research Programs (CDMRP). The...


Sep 18, 2017, 07:00 ET MeMed Completes Trilogy of Clinical Studies with More Than 2,000 Patients Validating First Ever Blood Test to Accurately Distinguish Between Bacterial and Viral Infections

MeMed today announced positive results from a large, external double-blinded PATHFINDER study that met its primary endpoint, independently confirming ...


Sep 18, 2017, 03:00 ET MeMed clôt un ensemble de trois études cliniques auxquelles ont participé plus de 2 000 patients, validant ainsi le tout premier test sanguin destiné à distinguer avec précision les infections bactériennes des infections virales

Résultats de l'étude PATHFINDER, une étude externe en double aveugle et de grande envergure , parue en ligne dans la revue Pediatrics L'étude montre...


Sep 18, 2017, 03:00 ET MeMed schließt drei klinische Studien mit mehr als 2.000 Patienten zur Validierung eines Bluttests zur Unterscheidung von bakteriellen und viralen Infektionen ab

Die Ergebnisse der umfangreichen, externen, doppelblinden Studie PATHFINDER wurde online in Pediatrics veröffentlicht Studie etabliert ImmunoXpert™...


Apr 19, 2017, 07:00 ET Verteidigungsministerium der Vereinigten Staaten vergibt Auftrag in Höhe von 9,2 Mio. USD an MeMed

Die Mittel werden dazu verwendet, die Entwicklung der allerersten patientennahen Labordiagnoseplattform zur Unterscheidung von bakteriellen und...


Apr 19, 2017, 07:00 ET MeMed signe un contrat de 9,2 millions de dollars avec le Département de la Défense des États-Unis

Les fonds seront utilisés pour achever le développement de la toute première plateforme de point de service à faire la distinction entre les...


Apr 19, 2017, 07:00 ET MeMed Awarded $9.2m Contract by US Department Of Defense

Funds will be used to complete the development of first ever point of care platform to distinguish bacterial from viral infections MeMed Ltd....


Apr 19, 2017, 07:00 ET MeMed Awarded $9.2M Contract by US Department of Defense

MeMed Ltd. announced today that it has been awarded a contract by the Defense Threat Reduction Agency (DTRA), a branch of the US Department of...


Apr 19, 2017, 07:00 ET MeMed Awarded $9.2m Contract by US Department Of Defense

Funds will be used to complete the development of first ever point of care platform to distinguish bacterial from viral infections MeMed Ltd....